Stock Earnings

Question 1

What are Alterity Therapeutics Limited's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Alterity Therapeutics Limited has a total asset of $0, Net loss of $-12

Question 2

What are the key financial ratios for PRNAF?

Accepted Answer

Alterity Therapeutics Limited's Current ratio is 0, has a Net margin is 0, sales per share of $0.

Question 3

How is Alterity Therapeutics Limited's revenue broken down by segment or geography?

Accepted Answer

Alterity Therapeutics Limited largest revenue segment is Water Utility Service, at a revenue of 63,434,000 in the most earnings release.For geography, United States is the primary market for Alterity Therapeutics Limited, at a revenue of 71,031,000.

Question 4

Is Alterity Therapeutics Limited profitable?

Accepted Answer

no, according to the latest financial statements, Alterity Therapeutics Limited has a net loss of $-12

Question 5

Does Alterity Therapeutics Limited have any liabilities?

Accepted Answer

no, Alterity Therapeutics Limited has liability of 0

Question 6

How many outstanding shares for Alterity Therapeutics Limited?

Accepted Answer

Alterity Therapeutics Limited has a total outstanding shares of 0

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
Revenue	1	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	7	5	4	5	5	7
Research & Development	16	14	18	13	14	12
Operating Expenses	17	14	19	14	15	15
Other Non Operating Income (Expenses)	2	2	0	0	0	0
Pretax Income	-14	-12	-19	-13	-12	-15
Income Tax Expense	0	0	0	0	0	0
Net Income	-14	-12	-19	-13	-12	-15
Net Income Growth	-26%	-37%	46%	8%	-20%	15%
Shares Outstanding (Diluted)	10,684.27	6,396.92	3,648.87	2,427.84	2,405.99	1,696.87
Shares Change (YoY)	109%	75%	50%	1%	42%	90%
EPS (Diluted)	0	0	0	0	0	0
EPS Growth	-60%	-63%	-9%	8%	-41%	-40%
Free Cash Flow	-22	-11	-12	-20	-12	-17
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	-1,600%	0%	0%	0%	0%	0%
Profit Margin	-1,400%	0%	0%	0%	0%	0%
Free Cash Flow Margin	-2,200%	0%	0%	0%	0%	0%
EBITDA	-16	-14	-19	-14	-15	-15
EBITDA Margin	-1,600%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-16	-14	-19	-14	-15	-15
EBIT Margin	-1,600%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Alterity Therapeutics Limited (PRNAF) Financial

PRNAF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is Alterity Therapeutics Limited?

PRNAF Income

Follow-Up Questions